 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «123456789101112 |
- ||||| Proventil (albuterol) / Merck (MSD)
Enrollment change: Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) (clinicaltrials.gov) - Aug 6, 2012
P3, N=345, Completed, Sponsor: Merck Sharp & Dohme Corp.
N=450 --> 345
- | fluticasone / Generic mfg.
New P4 trial, Combination therapy: Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients (clinicaltrials.gov) - Aug 2, 2012
P4, N=120, Recruiting, Sponsor: Far Eastern Memorial Hospital
- | Veramyst (fluticasone furoate nasal spray) / GSK
Trial completion: Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis (clinicaltrials.gov) - Jun 26, 2012
P4, N=41, Completed, Sponsor: Western Sky Medical Research
N=450 --> 345 Active, not recruiting --> Completed
- fluticasone / Generic mfg., esomeprazole / Generic mfg.
Trial completion: Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=42, Completed, Sponsor: Walter Reed Army Medical Center
Active, not recruiting --> Completed Recruiting --> Completed
- |||||||||| Xhance (fluticasone propionate intranasal spray) / OptiNose
New P3 trial: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device (clinicaltrials.gov) - Jun 17, 2012
P3, N=200, Recruiting, Sponsor: Optinose US Inc.
- fluticasone / Generic mfg.
Trial withdrawal: Azelastine Fluticasone Combination vs. Fluticasone (clinicaltrials.gov) - Jun 10, 2012
P4, N=0, Withdrawn, Sponsor: University of Dundee
Recruiting --> Completed Not yet recruiting --> Withdrawn
- fluticasone / Generic mfg.
Enrollment change: Azelastine Fluticasone Combination vs. Fluticasone (clinicaltrials.gov) - Jun 10, 2012
P4, N=0, Withdrawn, Sponsor: University of Dundee
Not yet recruiting --> Withdrawn N=20 --> 0
- QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
Enrollment change: PAW01: Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma (clinicaltrials.gov) - Jun 10, 2012
P4, N=15, Completed, Sponsor: University of Dundee
N=20 --> 0 N=24 --> 15
- QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
Trial completion: PAW01: Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma (clinicaltrials.gov) - Jun 10, 2012
P4, N=15, Completed, Sponsor: University of Dundee
N=24 --> 15 Recruiting --> Completed
- ||||| formoterol/fluticasone / Generic mfg., fluticasone / Generic mfg.
Trial initiation date, Head-to-Head: A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients (clinicaltrials.gov) - May 3, 2012
P3, N=222, Active, not recruiting, Sponsor: Eurofarma Laboratorios S.A.
Recruiting --> Completed Initiation date: Jan 2011 --> Jan 2012
- ||||| formoterol/fluticasone / Generic mfg., fluticasone / Generic mfg.
Enrollment closed, Head-to-Head: A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients (clinicaltrials.gov) - May 3, 2012
P3, N=222, Active, not recruiting, Sponsor: Eurofarma Laboratorios S.A.
Initiation date: Jan 2011 --> Jan 2012 Not yet recruiting --> Active, not recruiting
- | fluticasone / Generic mfg.
Enrollment change, IO biomarker: Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis (clinicaltrials.gov) - Apr 22, 2012
P2, N=35, Completed, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Active, not recruiting N=60 --> 35
- | fluticasone / Generic mfg.
Trial completion, IO biomarker: Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis (clinicaltrials.gov) - Apr 22, 2012
P2, N=35, Completed, Sponsor: Novartis Pharmaceuticals
N=60 --> 35 Active, not recruiting --> Completed
- |||| Trial completion: FACTO Study (Foster® As Complete Treatment Option) (clinicaltrials.gov) - Apr 19, 2012
P4, N=431, Completed, Sponsor: Chiesi Farmaceutici S.p.A.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- fluticasone / Generic mfg.
Enrollment change: Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma (clinicaltrials.gov) - Apr 10, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Kansas
Active, not recruiting --> Completed N=30 --> 0
- |||||||||| beclometasone/formoterol / Generic mfg., fluticasone / Generic mfg., fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
New P3 trial: A Study in Patients With Asthma (clinicaltrials.gov) - Apr 2, 2012
P3, N=90, Active, not recruiting, Sponsor: Chiesi Farmaceutici S.p.A.
- ||||||| fluticasone / Generic mfg., fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion: A Study in Patients With Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Apr 1, 2012
P3, N=373, Completed, Sponsor: Chiesi Farmaceutici S.p.A.
N=30 --> 0 Active, not recruiting --> Completed
- fluticasone / Generic mfg.
New P4 trial: Reversal of steroid insensitivity in COPD by theophylline (EUDRACT) - Jan 19, 2012
P4, N=30, Ongoing, Sponsor: imperial college
- fluticasone / Generic mfg.
Biomarker, Trial completion: Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma (clinicaltrials.gov) - Jan 17, 2012
P4, N=10, Completed, Sponsor: Associated Scientists to Help Minimize Allergies
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
New P3 trial: Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients (clinicaltrials.gov) - Jan 16, 2012
P3, N=498, Completed, Sponsor: Mundipharma Research Limited
- |||| AC-150 / Nicox
Trial completion: Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model (clinicaltrials.gov) - Jan 8, 2012
P2, N=83, Completed, Sponsor: Aciex Therapeutics, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | fluticasone / Generic mfg.
Trial completion: Topical Steroid Treatment for Eosinophilic Esophagitis (clinicaltrials.gov) - Oct 25, 2011
P2, N=42, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Xolair (omalizumab) / Roche, Novartis
New P4 trial: PROSE: Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (clinicaltrials.gov) - Sep 6, 2011
P4, N=494, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)